Log in to save to my catalogue

Effect of β2 -adrenergic receptor polymorphism on response to longacting β2 agonist in asthma (LARGE...

Effect of β2 -adrenergic receptor polymorphism on response to longacting β2 agonist in asthma (LARGE...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2914569

Effect of β2 -adrenergic receptor polymorphism on response to longacting β2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial

Publication information

Publisher

Kidlington: Elsevier

More information

Scope and Contents

Contents

Summary Background Some studies suggest that patients with asthma who are homozygous for arginine at the 16th aminoacid position of the β2 -adrenergic receptor (B16 Arg/Arg) benefit less from treatment with longacting β2 agonists and inhaled corticosteroids than do those homozygous for glycine (B16 Gly/Gly). We investigated whether there is a genot...

Alternative Titles

Full title

Effect of β2 -adrenergic receptor polymorphism on response to longacting β2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2914569

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2914569

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(09)61492-6

How to access this item